v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities:    
Net income (loss) $ 6,873,507 $ 314,122
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation 46,643 38,832
Common stock issued for services 35,200
Series B Preferred issued for services 14,100
Accounts receivable allowance 22,382 22,382
Fixed assets, net (35,242) 25,425
Acquired intangible assets 86,183 (24,908)
Change in assets and liabilities:    
Gross accounts receivable (192,899) (38,702)
Prepaid 61,689 (186,449)
Related party receivable 5,070,322 (1,446,098)
Accounts payable 335,875 235,223
Other current liabilities (490,392) (4,434,429)
Accrued interest (4,033) 67
Client funds payable 22,525,367 5,926,493
Fair value of trading position, net 1,111,487 143,164
Operating lease (48,292) (43,715)
Deferred taxes (5,636) 15,114
Tax receivable by subsidiaries 2,838 (7,612)
Trade receivable (88,986)
Accrued income 4,174 (250,316)
Right of use of assets (lease) 44,700 40,123
Accrued expenses, related party 470,259 7,500
Net cash provided by (used in) operating activities 35,789,946 385,516
Investing Activities:    
Capitalized software (98,107) (54,234)
Investment through subsidiary 1,552
Changes in paid-in capital, common control 4,430,650 676,789
Net cash provided by (used in) investing activities 4,334,095 622,555
Financing Activities:    
Borrowing from (payments to) line of credit 155,574 110,463
Net proceeds from cares act – paycheck protection program (3,272)
Net proceeds from SBA loan (2,126) (2,127)
Related party advances (25,376,291) (6,780,895)
Noncontrolling income (loss) (6,243) (21,310)
Change in noncontrolling interest 7,268 (2,621)
Net cash provided by (used in) financing activities (25,221,818) (6,699,762)
Effect of exchange rate changes on cash (110,212) 193,407
Net increase (decrease) in cash 14,792,011 (5,498,284)
Cash and cash equivalents, and restricted cash at beginning of the period 17,669,749 25,376,957
Cash and cash equivalents, and restricted cash at end of the period $ 32,461,760 $ 19,878,673